Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Teladoc Health, Inc. | 75,410 | reported | 03 Sept 2024 | tx 49+87,752−26,134 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 03 Sept 2024 | SALE | Teladoc Health, Inc. | 1,033 | 7.16 USD | |
| 30 Aug 2024 | EXERCISE | Teladoc Health, Inc. | 1,085 | — | |
| 30 Aug 2024 | EXERCISE | Teladoc Health, Inc. | 370 | — | |
| 30 Aug 2024 | EXERCISE | Teladoc Health, Inc. | 506 | — | |
| 30 Aug 2024 | EXERCISE | Teladoc Health, Inc. | 894 | — | |
| 30 Aug 2024 | EXERCISE | Teladoc Health, Inc. | 894 | 0.00 USD | deriv |
| 30 Aug 2024 | EXERCISE | Teladoc Health, Inc. | 506 | 0.00 USD | deriv |
| 30 Aug 2024 | EXERCISE | Teladoc Health, Inc. | 370 | 0.00 USD | deriv |
| 30 Aug 2024 | EXERCISE | Teladoc Health, Inc. | 1,085 | 0.00 USD | deriv |
| 09 Aug 2024 | EXERCISE | Teladoc Health, Inc. | 568 | — | |
| 12 Aug 2024 | SALE | Teladoc Health, Inc. | 206 | 7.14 USD | |
| 09 Aug 2024 | EXERCISE | Teladoc Health, Inc. | 568 | 0.00 USD | deriv |
| 02 Jul 2024 | SALE | Teladoc Health, Inc. | 442 | 9.39 USD | |
| 01 Jul 2024 | EXERCISE | Teladoc Health, Inc. | 1,233 | — | |
| 01 Jul 2024 | EXERCISE | Teladoc Health, Inc. | 1,233 | 0.00 USD | deriv |
| 31 May 2024 | EXERCISE | Teladoc Health, Inc. | 370 | — | |
| 31 May 2024 | EXERCISE | Teladoc Health, Inc. | 505 | — | |
| 31 May 2024 | EXERCISE | Teladoc Health, Inc. | 894 | — | |
| 03 Jun 2024 | SALE | Teladoc Health, Inc. | 1,040 | 11.16 USD | |
| 31 May 2024 | EXERCISE | Teladoc Health, Inc. | 1,085 | — | |
| 31 May 2024 | EXERCISE | Teladoc Health, Inc. | 370 | 0.00 USD | deriv |
| 31 May 2024 | EXERCISE | Teladoc Health, Inc. | 1,085 | 0.00 USD | deriv |
| 31 May 2024 | EXERCISE | Teladoc Health, Inc. | 894 | 0.00 USD | deriv |
| 31 May 2024 | EXERCISE | Teladoc Health, Inc. | 505 | 0.00 USD | deriv |
| 01 Apr 2024 | EXERCISE | Teladoc Health, Inc. | 1,232 | — |